Summary. During pseudopregnancy in the rabbit, plasma progesterone levels in the posterior vena cava fell rapidly from maximal concentrations of 9\ m=. \ 8 \ m=+-\ 0\ m=. \ 7 (s.e.m.) ng/ml on Day 13 of pseudopregnancy to 2\m=.\0 \ m=+-\ 0\m=.\6 ng/ml on Day 15. There was no significant increase in PGF levels at this time, although administration of indomethacin to a similar group of does delayed functional regression for over 7 days. Subcutaneous injection of 1 mg PGF-2\g=a\ or 35 mg arachidonic acid on Day 9 of pseudopregnancy resulted in loss of luteal function as plasma progesterone levels fell significantly from about 6 to < 1 ng/ml within 24 h. These findings indicate that the uterine factor responsible for luteolysis in the pseudopregnant rabbit may not be released in the form of PGF-2\g=a\.
Introduction
Hysterectomy delays CL regression in many laboratory and domestic animals. In the ewe, the uterine factor responsible for luteolysis is prostaglandin (PG) F-2rx: e.g. administration of this compound causes luteal regression, and, during the normal oestrous cycle, its release into the uterine vein is followed by a decline in progesterone secretion (McCracken, Baird & Goding, 1971 ;  Barcikowski, Carlson, Wilson & McCracken, 1974) . In addition, these authors have presented evidence that PGF-2a is transported to the ovary from the adjacent uterine horn by local transfer between the utero-ovarian vein and ovarian artery. Such a mechanism bypasses systemic dilution and metabolism.
Less is known about CL regression in the rabbit. In this species, PGF-2a treatment causes luteo¬ lysis (Gutknecht, Duncan & Wyngarden, 1972) and hysterectomy blocks the luteal regression which normally occurs at about Day 16 in pseudopregnant animals (Scott & Rennie, 1970) . However, in the rabbit there is no local utero-ovarian relationship (Hunter & Casida, 1967) or apposition of the utero-ovarian vein and ovarian artery (Del Campo & Ginther, 1972) , and the question therefore arises of how the uterine luteolytic factor is transported to the ovary. A possible explanation arises from the experiments of Hoffman (1974) Progesterone assay Progesterone concentrations were measured by a radioimmunoassay similar to that described by Abraham, Swerdloff, Tulchinsky & Odell (1971) . The antiserum was raised in a sheep immunized to progesterone-11-bovine serum albumin and was examined for cross-reaction with 17a-hydroxypregn-4-ene-3,20-dione, 20a-hydroxypregn-4-ene-3-one oestradiol-17ß and testosterone, steroids which are secreted by the rabbit ovary (Hilliard, Spies & Sawyer, 1968; Hilliard & Eaton, 1971 ; Waterston & Mills, 1976) , and cholesterol and oestradiol benzoate. By using the calculation procedure of Abraham (1969) , cross-reactivity was found to be less than 1 % for each of the above compounds. Because of the specificity of the antiserum, the chromatography step was omitted. The p-ogesterone tracer, [l,2,6,7-3H] progesterone (sp. act. 90-115 Ci/mmol), was supplied by New England Nuclear Corporation. For extraction, 0-1 ml plasma was used and each sample was assayed in duplicate. To calculate procedural losses, 1000 c.p.m. of labelled progesterone were added to each plasma sample before extraction and an aliquot was removed before incubation with antiserum. Recoveries ranged from 85 to 92 %. To test for accuracy, various amounts of progesterone were added to 0-1 ml plasma previously treated with charcoal to remove endogenous steroids. Addition of 50, 100, 200 and 300 pg resulted in mean ± s.e.m. (n = 10) estimates of 48-4 ± 7-2, 91-3 ± 3-6,183-3 ± 10-6 and 290-6 ± 13-3 pg of progesterone, respectively. Assay sensitivity was 50 pg/ml plasma. The intra-and inter-assay coefficients of variation were 5 and 8-8% respectively.
PGF assay
Plasma PGF levels were measured by using the radioimmunoassay procedure of Van Orden & Farley (1973) except that the chromatography step was omitted. Initial assays with split samples tested with and without chromatography showed excellent agreement. The antiserum was prepared as described by Stylos, Burstein, Rivetz, Gunsalus & Skarnes (1972) and examined for cross-reactivity (see Roberts, Carlson & McCracken, 1976) . In our laboratory, we have found this antiserum to be specific for PGF-2ct when tested with PGE-2 and the metabolites, 13,14-dihydroprostaglandin F-2a and 13,14-dihydro-15-keto-prostaglandin F-2a. The tracer, [5,6,8,9,ll,12,14,15-3H] prostagIandin F-2a (sp. act. 100-150 Ci/mmol), was obtained from New England Nuclear Corporation. Blood samples were mixed with the inhibitor of prostaglandin synthesis, indomethacin, at collection and 0-2 ml plasma was extracted for assay. Each sample was divided into 1 aliquot for recovery estimations and 2 aliquots for duplicate determinations in the assay. Recoveries ranged from 77 to 92 % and the inter-and intra-assay coefficients of variation were 6-2 and 4-5% respectively. PGF concentrations determined by this assay for jugular vein and carotid artery samples were 300-600 pg/ml and these values are similar to those reported by other workers for such samples. The arachidonic acid used for treatment of rabbits in Group 2 was tested in the PGF assay but no cross-reaction was found.
Results
Subcutaneous injection of 1 mg PGF-2a caused a sharp drop in the posterior vena cavai progesterone concentration in all rabbits in Group 1 : the mean ± s.e.m. values decreased from 6-5 ±1-8 ng/ml before treatment to 0-4 ± 0-1 ng/ml by 24 h (Text-fig. la) . A significant (P< 001) decline did not appear until 7 h after prostaglandin administration when progesterone concentration fell from 5-4 ± 0-5 ng/ml at 6 h to 3-3 ± 0-3 ng/ml at 7 h. Thereafter, the drop was steady but more gradual. Similarly, a significant decline in progesterone levels also occurred in the Group 2 rabbits treated with arachidonic acid (Text-fig. lb) . Although the control rabbits in Group 3 displayed pronounced variation in plasma progesterone concentrations over the 24 h collection period (Days 9-10), the mean level of this steroid in posterior vena cavai blood did not fall below 5-4 ng/ml (Text-fig. lc) . The PGF concentrations were 1-1-3-2, 1-3-2-4 and 1-3-1-7 ng/ml in Groups 1, 2 and 3 respectively.
In Group 4, the plasma progesterone concentrations increased to maximum levels on Day 13 (Text- fig. 2 ) and then fell sharply over the next 2 days (Table 1 ). In the indomethacin-injected rabbits in Group 5 luteolysis was delayed for several days (Text-fig. 3 ); progesterone concentrations fell to below 1 ng/ml only after Day 26 of pseudopregnancy, about 10 days after these low values had been reached in the untreated rabbits (Group 4). or arachidonic acid (Scott & Rennie, 1970; Gutknecht et al, 1972; Koering, 1974; Keyes & Bullock, 1974; Hoffman, 1974) , but also examined the sequential changes in plasma progesterone in each rabbit over a 24-h period. Previous investigations have shown that the uterus is required for luteolysis at the normal time in rabbits (Scott & Rennie, 1970; Hoffman, Davies & Davenport, 1973) and that there is no evidence for a local transfer of a luteolytic substance between the uterus and adjacent ovary (Einer-Jensen, 1974 ). Our present findings are consistent with synthesis of arachidonic acid in the rabbit endometrium and systemic transport to the ovary for conversion to PGF-2a. Wilks, Hunter & Norland (1972) have shown that the rabbit ovary is capable of synthesizing PGF-2a de novo. However, measurement of circulating arachidonic acid levels during luteolysis in the doe are needed before a firm conclusion can be made about the method of transfer of the luteolytic substance in the rabbit.
In the rabbit, the delay between prostaglandin treatment and CL regression appears to be longer than in the ewe (McCracken, Glew & Scaramuzzi, 1970; McCracken, Barcikowski, Carlson, Green & Samuelsson, 1973) . Although detailed studies of the effect of treatment with PGF-2a on proges¬ terone secretion in the pseudopregnant rabbit have not been carried out, in the pregnant doe PGF-2a causes an initial rapid drop (50%) in plasma progesterone concentration within 2 h, followed by a more gradual decline over the next 22 h (Bruce & Hiller, 1974; Challis, Porter & Ryan, 1974) . This delay may be a reflection of species differences in the control of CL function. For example, oestradiol-17ß is responsible for direct luteotrophic support in the rabbit (Keyes & Nalbandov, 1967) and it successfully antagonizes the luteolytic effect of PGF-2a when both are administered together (Gutknecht et al., 1972; Keyes & Bullock, 1974) . In contrast, LH, the principle luteotrophic hormone in the ewe, is unable to prevent the CL regression caused by PGF-2a when both are administered simultaneously (McCracken et al., 1973) . Therefore, in the rabbit circulating levels of oestrogen may interfere temporarily with the luteolytic effect of PGF-2a until ovarian levels of this prostaglandin are sufficient to overcome the luteotrophic stimulus.
In the present study, evidence of functional regression of the CL occurred between Days 14 and 15 of pseudopregnancy, 1 to 2 days before morphological evidence of regression was noted by Scott & Rennie (1970) (1973) reported that the gradual fall in peripheral progesterone which began after Day 13 in the pregnant rabbit was unaccompanied by an increase in peripheral PGF levels. However, in the cyclic ewe Barcikowski et al. (1974) found several large peaks of PGF-2rx concentrations in the utero-ovarian vein before CL regression. It therefore seems unlikely that in the pseudopregnant rabbit the uterine luteolysin is released in the form of PGF-2a unless it is altered to an active metabolite when it enters the uterine vein.
Loss of CL function occurred in pseudopregnant rabbits despite chronic indomethacin treatment. Similar observations have been made by O'Grady, Caldwell, Auletta & Speroff (1972) . The timing of the gradual decrease in progesterone secretion in indomethacin-treated animals coincides with the morphological changes observed for luteal tissue in hysterectomized, pseudopregnant does (Scott & Rennie, 1970; Hoffman et al., 1973) , and clearly the CL soon loses its ability to function when the luteolytic factor is removed by hysterectomy or blocked by an inhibitor. Although the mechanism responsible for regression at this time is unknown, it seems unlikely that it is related to a decline in circulating oestradiol-17ß levels. Miller & Keyes (1976) have reported that oestradiol implants, which maintained serum oestrogen at high concentrations, did not prevent CL regression in pseudo¬ pregnant does and the rabbit CL may lose its ability to respond to a luteotrophic stimulus, perhaps by the loss of an oestrogen receptor (Jacobson, Bullock & Keyes, 1972) .
